Drug Type Small molecule drug |
Synonyms RWJ 25730 |
Mechanism 5-HT1A receptor antagonists(Serotonin 1a (5-HT1a) receptor antagonists), D2 receptor antagonists(Dopamine D2 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H36N4O2 |
InChIKeyBLFPEKXTSDYQOQ-UHFFFAOYSA-N |
CAS Registry123547-30-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Behavioural disorders | Preclinical | - | - | |
Psychotic Disorders | Preclinical | US | - |